{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T12:31:44Z","timestamp":1769949104984,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,2,10]],"date-time":"2013-02-10T00:00:00Z","timestamp":1360454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s12035-013-8416-8","type":"journal-article","created":{"date-parts":[[2013,2,9]],"date-time":"2013-02-09T09:59:59Z","timestamp":1360403999000},"page":"186-189","source":"Crossref","is-referenced-by-count":38,"title":["Glaucoma: An Extension of Various Chronic Neurodegenerative Disorders"],"prefix":"10.1007","volume":"48","author":[{"given":"Vishal","family":"Jindal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,10]]},"reference":[{"key":"8416_CR1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:262\u2013267","journal-title":"Br J Ophthalmol"},{"key":"8416_CR2","first-page":"224","volume":"14","author":"M Mozaffarieh","year":"2008","unstructured":"Mozaffarieh M, Grieshaber MC, Flammer J (2008) Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol Vis 14:224\u2013233","journal-title":"Mol Vis"},{"key":"8416_CR3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00055735-200004000-00009","volume":"11","author":"G Tomita","year":"2000","unstructured":"Tomita G (2000) The optic nerve head in normal-tension glaucoma. Curr Opin Ophthalmol 11:116\u2013120","journal-title":"Curr Opin Ophthalmol"},{"key":"8416_CR4","first-page":"1077","volume":"43","author":"SJ McKinnon","year":"2002","unstructured":"McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, Merges CA, Pease ME, Kerrigan DF, Ransom NL, Tahzib NG, Reitsamer HA, Levkovitch-Verbin H, Quigley HA, Zack DJ (2002) Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 43:1077\u20131087","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8416_CR5","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","volume":"126","author":"Collaborative Normal-Tension Glaucoma Study Group","year":"1998","unstructured":"Collaborative Normal-Tension Glaucoma Study Group (1998) The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 126:498\u2013505","journal-title":"Am J Ophthalmol"},{"key":"8416_CR6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000047976","volume":"47","author":"AU Bayer","year":"2002","unstructured":"Bayer AU, Ferrari F, Erb C (2002) High occurrence rate of glaucoma among patients with Alzheimer\u2019s disease. Eur Neurol 47:165\u2013168","journal-title":"Eur Neurol"},{"key":"8416_CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9394(01)01196-5","volume":"133","author":"AU Bayer","year":"2002","unstructured":"Bayer AU, Keller ON, Ferrari F, Maag KP (2002) Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer\u2019s disease and Parkinson\u2019s disease. Am J Ophthalmol 133:135\u2013137","journal-title":"Am J Ophthalmol"},{"key":"8416_CR8","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","volume":"289","author":"T Sunderland","year":"2003","unstructured":"Sunderland T, Linker G, Mirza N, Putnam KT, Friedman DL, Kimmel LH, Bergeson J, Manetti GJ, Zimmermann M, Tang B, Bartko JJ, Cohen RM (2003) Decreased \u03b2-amyloid1\u201342 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 289:2094\u20132103","journal-title":"JAMA"},{"key":"8416_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10384-004-0156-x","volume":"49","author":"S Yoneda","year":"2005","unstructured":"Yoneda S, Hara H, Hirata A, Fukushima M, Inomata Y, Tanihara H (2005) Vitreous fluid levels of \u03b2-amyloid1\u201342 and tau in patients with retinal diseases. Jpn J Ophthalmol 49:106\u2013108","journal-title":"Jpn J Ophthalmol"},{"key":"8416_CR10","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1073\/pnas.0703707104","volume":"104","author":"L Guo","year":"2007","unstructured":"Guo L, Salt TE, Luong V, Wood N, Cheung W, Maass A, Ferrari G, Russo-Marie F, Sillito AM, Cheetham ME, Moss SE, Fitzke FW, Cordeiro MF (2007) Targeting amyloid-\u03b2 in glaucoma treatment. Proc Natl Acad Sci USA 104:13444\u201313449","journal-title":"Proc Natl Acad Sci USA"},{"key":"8416_CR11","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1167\/iovs.06-1249","volume":"48","author":"D Goldblum","year":"2007","unstructured":"Goldblum D, Kipfer-Kauer A, Sarra GM, Wolf S, Frueh BE (2007) Distribution of amyloid precursor protein and amyloid-\u03b2 immunoreactivity in DBA\/2J glaucomatous mouse retinas. Invest Ophthalmol Vis Sci 48:5085\u20135090","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8416_CR12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1471-4159.2008.05606.x","volume":"107","author":"M Shimazawa","year":"2008","unstructured":"Shimazawa M, Inokuchi Y, Okuno T, Nakajima Y, Sakaguchi G, Kato A, Oku H, Sugiyama T, Kudo T, Ikeda T, Takeda M, Hara H (2008) Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling. J Neurochem 107:279\u2013290","journal-title":"J Neurochem"},{"key":"8416_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2006.02.009","volume":"246","author":"H Tamura","year":"2006","unstructured":"Tamura H, Kawakami H, Kanamoto T et al (2006) High frequency of open-angle glaucoma in Japanese patients with Alzheimer\u2019s disease. J Neurol Sci 246:79\u201383","journal-title":"J Neurol Sci"},{"key":"8416_CR14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj\/eye\/6700034","volume":"16","author":"AU Bayer","year":"2002","unstructured":"Bayer AU, Ferrari F (2002) Severe progression of glaucomatous optic neuropathy in patients with Alzheimer\u2019s disease. Eye 16:209\u2013212","journal-title":"Eye"},{"key":"8416_CR15","first-page":"1077","volume":"43","author":"SJ McKinnon","year":"2002","unstructured":"McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA et al (2002) Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 43:1077\u20131087","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8416_CR16","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3109\/02713683.2010.494240","volume":"35","author":"A Kipfer-Kauer","year":"2010","unstructured":"Kipfer-Kauer A, McKinnon SJ, Frueh BE, Goldblum D (2010) Distribution of amyloid precursor protein and amyloid-beta in ocular hypertensive C57BL\/6 mouse eyes. Curr Eye Res 35:828\u2013834","journal-title":"Curr Eye Res"},{"key":"8416_CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3129\/i07-185","volume":"43","author":"N Gupta","year":"2008","unstructured":"Gupta N, Fong J, Ang LC, Yucel YH (2008) Retinal tau pathology in human glaucomas. Can J Ophthalmol 43:53\u201360","journal-title":"Can J Ophthalmol"},{"key":"8416_CR18","doi-asserted-by":"crossref","unstructured":"Corr\u02c6ea S, Eales K (2012) The Role of p38 MAPK and its substrates in neuronal plasticity and neurodegenerative disease. J Signal Transduct. doi: 10.1155\/2012\/649079","DOI":"10.1155\/2012\/649079"},{"key":"8416_CR19","first-page":"2127","volume":"18","author":"Y Yang","year":"2012","unstructured":"Yang Y, Liu X, Huang J, Zhong Y, Mao Z, Xiao H, Mei Li M, Zhuo Y (2012) Inhibition of p38 mitogen-activated protein kinase phosphorylation decrease tert-butyl hydroperoxide-induced apoptosis in human trabecular meshwork cells. Mol Vis 18:2127\u20132136","journal-title":"Mol Vis"},{"key":"8416_CR20","doi-asserted-by":"crossref","first-page":"12957","DOI":"10.1523\/JNEUROSCI.1064-09.2009","volume":"41","author":"H Abdul","year":"2009","unstructured":"Abdul H, Sama M, Furman J, Mathis D, Beckett T, Weidner A, Patel E, Baig I, Paul Murphy M, LeVine H, Kraner S, Norris C (2009) Cognitive decline in Alzheimer\u2019s disease is associated with selective changes in calcineurin\/NFAT signaling. J Neurosci 41:12957\u201312969","journal-title":"J Neurosci"},{"key":"8416_CR21","first-page":"2828","volume":"18","author":"J Qu","year":"2012","unstructured":"Qu J, Matsouaka R, Betensky R, Hyman B, Grosskreutznz C (2012) Calcineurin activation causes retinal ganglion cell degeneration. Mol Vis 18:2828\u20132838","journal-title":"Mol Vis"},{"key":"8416_CR22","first-page":"55","volume":"49","author":"IM Cojocaru","year":"2011","unstructured":"Cojocaru IM, Cojocaru M, Miu G, Sapira V (2011) Study of interleukin-6 production in Alzheimer\u2019s disease V. Rom J Intern Med 49:55\u201358","journal-title":"Rom J Intern Med"},{"key":"8416_CR23","first-page":"168","volume":"1","author":"S Sims","year":"2012","unstructured":"Sims S, Holmgren L, Cathcart H, Sappington R (2012) Spatial regulation of interleukin-6 signaling in response to neurodegenerative stressors in the retina. Am J Neurodegener Dis 1:168\u2013179","journal-title":"Am J Neurodegener Dis"},{"issue":"suppl 3","key":"8416_CR24","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1177\/112067210301303S06","volume":"13","author":"N Gupta","year":"2003","unstructured":"Gupta N, Yucel YH (2003) Brain changes in glaucoma. Eur J Ophthalmol 13(suppl 3):S32\u2013S35","journal-title":"Eur J Ophthalmol"},{"key":"8416_CR25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.coph.2012.09.008","volume":"13","author":"V Chrysostomou","year":"2013","unstructured":"Chrysostomou V, Rezania F, Trounce A, Crowston G (2013) Oxidative stress and mitochondrial dysfunction in glaucoma. Curr Opin Pharmacol 13:12\u201315","journal-title":"Curr Opin Pharmacol"},{"key":"8416_CR26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.preteyeres.2006.07.003","volume":"25","author":"G Tezel","year":"2006","unstructured":"Tezel G (2006) Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 25:490\u2013513","journal-title":"Prog Retin Eye Res"},{"key":"8416_CR27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.brainres.2005.03.037","volume":"1045","author":"S Holasek","year":"2005","unstructured":"Holasek S, Wengenack M, Kandimalla K, Montano C, Gregor M, Curran L, Poduslo F (2005) Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice. Brain Res 1045:185\u2013198","journal-title":"Brain Res"},{"key":"8416_CR28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0161-813X(02)00099-2","volume":"23","author":"DA Monte Di","year":"2002","unstructured":"Di Monte DA, Lavasani M, Manning-Bog AB (2002) Environmental factors in Parkinson\u2019s disease. Neurotoxicology 23:487\u2013502","journal-title":"Neurotoxicology"},{"key":"8416_CR29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/mds.870090202","volume":"9","author":"AH Schapira","year":"1994","unstructured":"Schapira AH (1994) Evidence for mitochondrial dysfunction in Parkinson\u2019s disease\u2014a critical appraisal. Mov Disord 9:125\u2013138","journal-title":"Mov Disord"},{"key":"8416_CR30","first-page":"83","volume":"86","author":"PL McGeer","year":"2001","unstructured":"McGeer PL, Yasojima K, McGeer EG (2001) Inflammation in Parkinson\u2019s disease. Adv Neurol 86:83\u201389","journal-title":"Adv Neurol"},{"key":"8416_CR31","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","volume":"97","author":"B Halliwell","year":"2006","unstructured":"Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634\u20131658","journal-title":"J Neurochem"},{"key":"8416_CR32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0733-8619(05)70259-0","volume":"14","author":"CM Tanner","year":"1996","unstructured":"Tanner CM, Goldman SM (1996) Epidemiology of Parkinson\u2019s disease. Neurol Clin 14:317\u2013335","journal-title":"Neurol Clin"},{"key":"8416_CR33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuint.2005.12.002","volume":"48","author":"C Julien","year":"2006","unstructured":"Julien C, Berthiaume L, Hadj-Tahar A, Rajput AH, Bedard PJ, Di Paolo T, Julien P, Calon F (2006) Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys. Neurochem Int 48:404\u2013414","journal-title":"Neurochem Int"},{"key":"8416_CR34","first-page":"109","volume-title":"New protective roles for selected nutrients","author":"N Salem Jr","year":"1989","unstructured":"Salem N Jr (1989) Omega-3 fatty acids: molecular and biochemical aspects. In: Spiller GA, Scala J (eds) New protective roles for selected nutrients. Liss, New York, pp 109\u2013228"},{"key":"8416_CR35","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s11745-001-0805-6","volume":"36","author":"AR Liss","year":"2001","unstructured":"Liss AR, New York Salem N Jr, Litman B, Kim HY, Gawrisch K (2001) Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36:945\u2013959","journal-title":"Lipids"},{"key":"8416_CR36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0304-4165(73)90148-7","volume":"320","author":"WC Breckenridge","year":"1973","unstructured":"Breckenridge WC, Morgan IG, Zanetta JP, Vincendon G (1973) Adult rat brain synaptic vesicles. II. Lipid composition. Biochim Biophys Acta 320:681\u2013686","journal-title":"Biochim Biophys Acta"},{"key":"8416_CR37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1471-4159.2002.01015.x","volume":"82","author":"M Akbar","year":"2002","unstructured":"Akbar M, Kim HY (2002) Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J Neurochem 82:655\u2013665","journal-title":"J Neurochem"},{"key":"8416_CR38","doi-asserted-by":"crossref","first-page":"10858","DOI":"10.1073\/pnas.0502903102","volume":"102","author":"M Akbar","year":"2005","unstructured":"Akbar M, Calderon F, Wen Z, Kim HY (2005) Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci U S A 102:10858\u201310863","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8416_CR39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1460-9568.2005.04253.x","volume":"22","author":"F Calon","year":"2005","unstructured":"Calon F, Lim GP, Morihara T, Yang F, Ubeda O, Salem N Jr, Frautschy SA, Cole GM (2005) Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer\u2019s disease. Eur J Neurosci 22:617\u2013626","journal-title":"Eur J Neurosci"},{"key":"8416_CR40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.neuron.2004.08.013","volume":"43","author":"F Calon","year":"2004","unstructured":"Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, Salem N Jr, Ashe KH, Frautschy SA, Cole GM (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer\u2019s disease mouse model. Neuron 43:633\u2013645","journal-title":"Neuron"},{"key":"8416_CR41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00041433-200204000-00007","volume":"13","author":"DB Jump","year":"2002","unstructured":"Jump DB (2002) Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol 13:155\u2013164","journal-title":"Curr Opin Lipidol"},{"key":"8416_CR42","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1096\/fj.07-9677com","volume":"22","author":"M Bousquet","year":"2008","unstructured":"Bousquet M, Saint-Pierre M, Julien C, Salem N, Cicchetti F, Calon F (2008) Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson\u2019s disease. FASEB J 22:1213\u20131225","journal-title":"FASEB J"},{"key":"8416_CR43","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1083\/jcb.200602101","volume":"172","author":"T Boiko","year":"2006","unstructured":"Boiko T, Winckler B (2006) Myelin under construction: teamwork required. J Cell Biol 172:799\u2013801","journal-title":"J Cell Biol"},{"key":"8416_CR44","first-page":"386","volume":"10","author":"JM Bourre","year":"2006","unstructured":"Bourre JM (2006) Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J Nutr Health Aging 10:386\u2013399","journal-title":"J Nutr Health Aging"},{"key":"8416_CR45","first-page":"79","volume":"58","author":"I Wojda","year":"2012","unstructured":"Wojda I (2012) MAP kinase pathways\u2014their evolution and role in some neurodegenerative diseases. Postepy Biochem 58:79\u201390","journal-title":"Postepy Biochem"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-013-8416-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-013-8416-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-013-8416-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T14:32:54Z","timestamp":1562682774000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-013-8416-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,10]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["8416"],"URL":"https:\/\/doi.org\/10.1007\/s12035-013-8416-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,10]]}}}